Jounce Therapeutics Investor Relations Material
Latest events
Business Combination
Jounce Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Jounce Therapeutics Inc
Access all reports
Jounce Therapeutics Inc. is a clinical-stage biotechnology company focused on developing immunotherapies for the treatment of cancer. The company leverages its expertise in immuno-oncology to discover and develop therapies that stimulate the immune system to recognize and attack tumors. Jounce's pipeline includes a range of biologic therapies that target various immune pathways, with the goal of improving patient outcomes in solid tumor cancers. The company collaborates with academic institutions and industry partners to advance its therapeutic candidates. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the Nasdaq.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
JNCE
Country
🇺🇸 United States